UnitedHealth Group (NYSE:UNH) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS

UnitedHealth Group (NYSE:UNH) announced its quarterly earnings results on Tuesday. The healthcare conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02, Zacks reports. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $113.22 billion for the quarter, compared to analyst estimates of $113.38 billion. During the same quarter in the prior year, the business earned $6.81 EPS. UnitedHealth Group’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group updated its FY 2026 guidance to 17.750- EPS.

Here are the key takeaways from UnitedHealth Group’s conference call:

• 2026 financial guidance: UnitedHealth expects adjusted EPS of greater than $17.75 (at least +8.6% growth) with revenues around $440 billion and continued strong cash generation, signaling management’s confidence in margin recovery and operating improvements.
• Membership will meaningfully shrink in 2026 as UnitedHealthcare repriced plans: company expects a total risk-member contraction of about 2.3–2.8 million, including 1.3–1.4 million Medicare Advantage lives and ~565k–715k Medicaid members.
• Reported a largely non?cash, $1.6 billion net-of-tax charge tied mainly to Optum actions — including cyber?attack true-ups (~$800M), portfolio exits (~$440M gain component) and broad restructuring (with a ~$625M lost?contract reserve) — reflecting remediation costs and strategic exits.
• Optum momentum and productivity: Optum Rx added ~800 new clients and the Optum segments target low?to?high single?digit adjusted earnings growth (with margin expansion across Rx, Insight and Health); management expects nearly $1 billion of 2026 AI?enabled operating cost savings and plans ~$1.5 billion of tech/AI investment in 2026.
• Regulatory risk: CMS’s 2027 Advance Notice would further cut Medicare funding and appears to understate current medical utilization, potentially forcing additional benefit reductions, footprint changes and sector?wide access/affordability pressure.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $294.08 on Thursday. The company has a quick ratio of 0.82, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The firm has a market capitalization of $266.39 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 1.69 and a beta of 0.42. UnitedHealth Group has a twelve month low of $234.60 and a twelve month high of $606.36. The stock’s 50-day simple moving average is $331.78 and its 200 day simple moving average is $323.60.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 3.0%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s dividend payout ratio is currently 46.14%.

Analyst Ratings Changes

Several analysts recently weighed in on UNH shares. Leerink Partners dropped their price target on UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a report on Wednesday. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a research note on Friday, January 23rd. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective on the stock. in a research note on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $380.67.

Institutional Trading of UnitedHealth Group

A number of hedge funds have recently added to or reduced their stakes in UNH. Imprint Wealth LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth $33,000. Riggs Asset Managment Co. Inc. raised its position in UnitedHealth Group by 69.4% in the second quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 43 shares during the last quarter. Turning Point Benefit Group Inc. bought a new stake in shares of UnitedHealth Group during the third quarter worth about $41,000. Mpwm Advisory Solutions LLC increased its position in UnitedHealth Group by 1,090.9% in the 3rd quarter. Mpwm Advisory Solutions LLC now owns 131 shares of the healthcare conglomerate’s stock valued at $45,000 after acquiring an additional 120 shares during the period. Finally, Binnacle Investments Inc grew its stake in shares of UnitedHealth Group by 185.8% in the second quarter. Binnacle Investments Inc now owns 383 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 249 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q4 beat on EPS and margin commentary — UnitedHealth reported Q4 EPS of $2.11, slightly above consensus, and highlighted Optum Rx strength and margin initiatives that management says will support profitability. This gives some near-term earnings credibility despite revenue softness. MarketBeat Q4 coverage
• Positive Sentiment: Capital returns remain a cushion — analysts and commentators note UNH’s dividend and ongoing buybacks (share-count reduction planned) support the equity’s floor and long-term shareholder returns. That underpins buy-the-dip arguments. MarketBeat: Buying opportunity
• Neutral Sentiment: Allegations of timely politician sales are drawing attention — reports show some lawmakers sold UNH shares before the plunge; this is a political/PR risk but not a fundamental earnings driver. Watch regulatory/oversight headlines. Finbold: Politician sales
• Negative Sentiment: Weak 2026 guidance — management guided to roughly $439B in 2026 revenue (down from 2025), signaling a rare revenue contraction tied to “right-sizing” and lower reimbursement expectations; this is the principal reason investors stampeded out. Investopedia: Guidance and drivers
• Negative Sentiment: CMS/Medicare payment proposal (Trump administration) — a much-smaller-than-expected proposed increase to Medicare Advantage payments materially reduces forward reimbursement assumptions for insurers and magnified UNH’s guidance concerns. That policy news triggered the sector sell-off. Benzinga: Medicare rates reaction
• Negative Sentiment: Analysts cut price targets — multiple firms trimmed 12–30% off prior targets (Jefferies, Leerink, Oppenheimer, RBC, UBS), keeping buy/outperform ratings but lowering upside expectations — adds short-term selling pressure. TickerReport / Benzinga aggregation
• Negative Sentiment: Large one-day market cap hit and volatility — UNH lost tens of billions in market value and dragged the Dow lower; that amplifies risk aversion and forces some funds to trim exposure. InsiderMonkey: Market impact

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.